Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: Additional results from a randomized trial

Arthritis Care and Research

Volumn 61, Issue 2, 2009, Pages 209-215

  Morrish, Donald W ^a   Beaupre, Lauren A ^a   Bell, Neil R ^a   Cinats, John G ^a   Hanley, David A ^a   Harley, Charles H ^b   Juby, Angela G ^a   Lier, Douglas A ^a   Maksymowych, Walter P ^a   Majumdar, Sumit R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; RISEDRONIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE MASS; CASE MANAGEMENT; CASE MANAGER; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP FRACTURE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CASE MANAGEMENT; CRITICAL PATHWAYS; DIPHOSPHONATES; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);

EID: 62549105700     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24097     Document Type: Article

References (31)

1. Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 2003;163:2052-7.
2. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003;163:2165-72.
3. Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004;15: 767-78.
4. Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, et al. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 2003;88:3482-6.
5. Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE. Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 2000;109:326-8.
6. Torgerson DJ, Dolan P. Prescribing by general practitioners after an osteoporotic fracture. Ann Rheum Dis 1998;57:378-9.
7. Follin SL, Black JN, McDermott MT. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotherapy 2003;23:190-8.
8. Juby AG, de Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 2002;13:205-10.
9. Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA. Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 2002;47:651-4.
10. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 2007;357:1799-809.
11. Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A, et al. Interventions to improve osteoporosis treatment following hip fracture: a prospective randomized trial. J Bone Joint Surg Am 2005;87:3-7.
12. Fisher AA, Davis MW, Rubenach SE, Sivakumaran S, Smith PN, Budge MM. Outcomes for older patients with hip fractures: the impact of orthopedic and geriatric medicine cocare. J Orthop Trauma 2006;20:172-80.
13. Lowdon DW, Quinn C, Mole P, Leese GP. Osteoporosis assessment and treatment in older patients who have sustained a hip fracture. Scott Med J 2006;51:32-5.
14. Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG, et al. Use of a case manager to improve osteoporosis treatment after hip fracture. Arch Intern Med 2007;167:1-6.
15. Brown JP, Josse RG, for the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167 Suppl 10:S1-34.
16. National Osteoporosis Foundation. 2003 physicians' guide to prevention and treatment of osteoporosis. 2003. URL: http://www.nof.org/physguide/index. asp.
17. Feldstein AC, Nichols G, Orwoll E, Elmer PJ, Smith DH, Herson M, et al. The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int 2005;16:953-62.
18. Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, et al. A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 2004;141:366-73.
19. Harrington JT, Barash HL, Day S, Lease J. Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 2005;53:198-204.
20. Simonelli C, Killeen K, Mehle S, Swanson L. Barriers to osteoporosis identification and treatment among primary care physicians and orthopaedic surgeons. Mayo Clin Proc 2002;77:334-8.
21. Zafran N, Liss Z, Peled R, Sherf M, Reuveni H. Incidence and causes for failure of treatment of women with proven osteoporosis. Osteoporos Int 2005;16:1375-83.
22. Majumdar SR. Recent trends in osteoporosis treatment after hip fracture: improving but wholly inadequate. J Rheumatol 2008;35:190-2.
23. McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 2004;14:1028-34.
24. Murray AW, McQuillan C, Kennon B, Gallacher SJ. Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture: a comparison of two centres in the United Kingdom. Injury 2005;36:1080-4.
25. Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG, et al. Osteoporosis case-manager for hip fracture patients: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med. In press.
26. Sander B, Elliott-Gibson V, Beaton DE, Bogoch ER, Maetzel A. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 2008;90:1197-205.
27. Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, et al. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women [review]. Cochrane Database Syst Rev 2008;1:CD004523.
28. Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papa- ioannou A, et al, the Osteoporosis Methodology Group, and the Osteoporosis Research Advisory Group. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocrinol Rev 2008;23:517-23.
29. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, et al, the Osteoporosis Methodology Group, and the Osteoporosis Research Advisory Group. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocrinol Rev 2008;23:508-16.
30. Cochrane Effective Practice and Organization of Care Group. URL: http://www.epoc.cochrane.org/en/index.html.
31. Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, et al. Trends in drug prescribing for osteoporosis after hip fracture: 1995-2004. J Rheumatol 2008;35:319-26.